{"quote": {"result": [{"language": "en-US", "region": "US", "quoteType": "EQUITY", "typeDisp": "Equity", "quoteSourceName": "Delayed Quote", "triggerable": false, "customPriceAlertConfidence": "LOW", "currency": "EUR", "esgPopulated": false, "market": "dr_market", "longName": "Akeso, Inc.", "marketState": "REGULAR", "regularMarketPrice": 5.05, "messageBoardId": "finmb_660797233", "exchange": "FRA", "shortName": "AKESO INC.  O.N.", "exchangeTimezoneShortName": "CEST", "exchangeTimezoneName": "Europe/Berlin", "regularMarketChangePercent": -0.98038656, "gmtOffSetMilliseconds": 7200000, "fiftyTwoWeekLowChange": 3.6000001, "fiftyTwoWeekLowChangePercent": 2.4827585, "fiftyTwoWeekRange": "1.45 - 6.0", "fiftyTwoWeekHighChange": -0.9499998, "fiftyTwoWeekHighChangePercent": -0.1583333, "fiftyTwoWeekLow": 1.45, "fiftyTwoWeekHigh": 6.0, "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": 0.0, "epsTrailingTwelveMonths": -0.19, "firstTradeDateMilliseconds": 1588053600000, "priceHint": 2, "regularMarketChange": -0.049999714, "regularMarketTime": 1683874726, "regularMarketDayHigh": 5.05, "regularMarketDayRange": "5.05 - 5.05", "regularMarketDayLow": 5.05, "regularMarketVolume": 100, "regularMarketPreviousClose": 5.1, "bid": 4.78, "ask": 5.2, "fullExchangeName": "Frankfurt", "financialCurrency": "CNY", "regularMarketOpen": 5.05, "averageDailyVolume3Month": 15, "averageDailyVolume10Day": 30, "sharesOutstanding": 841057024, "bookValue": 3.134, "fiftyDayAverage": 4.7918, "fiftyDayAverageChange": 0.25820017, "fiftyDayAverageChangePercent": 0.053883754, "twoHundredDayAverage": 4.14445, "twoHundredDayAverageChange": 0.90555, "twoHundredDayAverageChangePercent": 0.21849702, "marketCap": 4303988736, "priceToBook": 1.6113594, "sourceInterval": 15, "exchangeDataDelayedBy": 15, "tradeable": false, "cryptoTradeable": false, "symbol": "4RY.F"}], "error": null}, "summary": {"result": [{"assetProfile": {"address1": "No. 6, Shennong Road", "address2": "Torch Development Zone", "city": "Zhongshan", "zip": "528437", "country": "China", "phone": "86 76 0898 73998", "fax": "86 76 0898 73900", "website": "https://www.akesobio.com", "industry": "Biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "longBusinessSummary": "Akeso, Inc., a biopharmaceutical company, researches, develops, manufactures, and commercializes therapies. The company develops AK104, a PD-1/CTLA-4 bi-specific antibody to treat cervical cancer, gastric cancer (GC), gastroesophageal junction (GEJ) cancer, ESCC, hepatocellular carcinoma (HCC), small cell lung cancer (SCLC), non-small cell lung cancer (NSCLC), pancreatic cancer, and solid tumors; and AK112, a PD-1/VEGF bi-specific antibody to treat NSCLC, triple-negative breast cancer (TNBC), head and neck cancer, HCC, colorectal and ovarian cancer, and solid tumors. It is also developing AK105, a PD-1 monoclonal antibody to treat classic Hodgkin's lymphoma (R/R cHL), NSCLC, NPC, HCC, SCLC, thyroid cancer, mesothelioma and thymic cancer, ESCC, UC, GC, GEJ, cholangiocarcinoma, neuroendocrine tumor, and mismatch repair deficient solid tumor; AK117, a CD47 monoclonal antibody to treat myelodysplastic syndrome, acute myeloid leukemia, GC, GEJ, ESCC, HNSCC, CRC, TNBC, and solid tumors/lymphoma; AK119, a CD73 monoclonal antibody for treating solid tumors and NSCLC; and AK109, a VEGFR-2 monoclonal antibody to treat GC, GEJ, NSCLC, HCC, and solid tumors. In addition, the company develops AK102, a PCSK9 monoclonal antibody to treat hypercholesterolemia and mixed hyperlipidemia; AK101, an IL-12/IL-23 monoclonal antibody to treat moderate-to-severe psoriasis and ulcerative colitis; AK111, an IL-17 monoclonal antibody to treat moderate-to-severe psoriasis and ankylosing spondylitis; and AK120, an IL-4R monoclonal antibody to treat moderate-to-severe atopic dermatitis. Further, its preclinical product includes AK127, a TIGIT monoclonal antibody to treat solid tumors; and AK115, a NGF monoclonal antibody. The company has collaboration agreements with Pfizer Pharmaceuticals; AstraZeneca Pharmaceuticals; Summit Therapeutics Inc.; and Shenzhen Chipscreen Biosciences Co., Ltd. Akeso, Inc. was founded in 2012 and is headquartered in Zhongshan, the People's Republic of China.", "fullTimeEmployees": 2341, "companyOfficers": [{"maxAge": 1, "name": "Dr. Yu  Xia Ph.D.", "age": 55, "title": "Founder, CEO, Pres & Chairwoman", "yearBorn": 1967, "fiscalYear": 2021, "totalPay": {"raw": 1021130, "fmt": "1.02M", "longFmt": "1,021,130"}, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Dr. Baiyong  Li Ph.D.", "age": 53, "title": "Co-Founder, Exec. VP, CSO & Exec. Director", "yearBorn": 1969, "fiscalYear": 2021, "totalPay": {"raw": 606341, "fmt": "606.34k", "longFmt": "606,341"}, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Mr. Zhongmin  Wang Ph.D.", "age": 53, "title": "Co-Founder, Sr. VP & Exec. Director", "yearBorn": 1969, "fiscalYear": 2021, "totalPay": {"raw": 487665, "fmt": "487.67k", "longFmt": "487,665"}, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Mr. Yu  Xia Ph.D.", "age": 51, "title": "Sr. VP & Exec. Director", "yearBorn": 1971, "fiscalYear": 2021, "totalPay": {"raw": 577392, "fmt": "577.39k", "longFmt": "577,392"}, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Dr. Peng  Zhang Ph.D.", "title": "Co-Founder & Sr. VP", "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Dr. Xinfeng  Zhang", "title": "Sr. VP", "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Mr. Wenjun  Shi", "title": "Sr. VP", "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Dr. Mingxiu  Hu Ph.D.", "title": "Sr. VP", "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Ms. Wai Yan  Leung", "title": "Company Sec.", "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}], "compensationAsOfEpochDate": 1640908800, "maxAge": 86400}}], "error": null}}